Abbas D, Zhu LC, Moon AM (2022) Elevated liver enzymes in a patient with hepatocellular carcinoma on immune checkpoint inhibitor therapy: a diagnostic and therapeutic challenge. ACG Case Rep J 9:e00834. https://doi.org/10.14309/crj.0000000000000834

Aebi HE (1983) Catalase. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 3. Chemie, Weinheim, pp 273–286

Google Scholar 

Alberts CJ, Clifford GM, Georges D, Negro F, Lesi OA, Hutin YJ, de Martel C (2022) Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review. Lancet Gastroenterol Hepatol 7:724–735. https://doi.org/10.1016/S2468-1253(22)00050-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F (2020) Global burden of 5 major types of gastrointestinal cancer. Gastroenterol 159:335–349. https://doi.org/10.1053/j.gastro.2020.02.068

Article  Google Scholar 

Ashwani K, Dhingra BC, Ajmer SG, Kumar G (2022) Pharmacological properties of chebulinic acid and related ellagitannins from nature: an emerging contemporary bioactive entity. Pharmacol Res Mod Chin Med 5:100163. https://doi.org/10.1016/j.prmcm.2022.100163

Article  Google Scholar 

Avula B, Wang YH, Wang M, Shen YH, Khan IA (2013) Simultaneous determination and characterization of tannins and triterpene saponins from the fruits of various species of Terminalia and Phyllantus emblica using a UHPLC-UV-MS method: application to triphala. Planta Med 79:181–188. https://doi.org/10.1055/s-0032-1328089

Article  CAS  PubMed  Google Scholar 

Baliga MS, Meera S, Mathai B, Rai MP, Pawar V, Palatty PL (2012) Scientific validation of the ethnomedicinal properties of the Ayurvedic drug triphala: a review. Chin J Integr Med 18:946–954. https://doi.org/10.1007/s11655-012-1299-x

Article  PubMed  Google Scholar 

Baliga MS (2010) Triphala, ayurvedic formulation for treating and preventing cancer: a review. J Altern Complement Med 16:1301–1308. https://doi.org/10.1089/acm.2009.0633

Article  PubMed  Google Scholar 

Baratakke SU, Raju R, Kadanakuppe S, Savanur NR, Gubbihal R, Kousalaya PS (2017) Efficacy of triphala extract and chlorhexidine mouth rinse against plaque accumulation and gingival inflammation among female undergraduates: a randomized controlled trial. Indian J Dent Res 28:49–54. https://doi.org/10.4103/0970-9290.203622

Article  PubMed  Google Scholar 

Behrens A, Jochum W, Sibilia M, Wagner EF (2000) Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation. Oncogene 19:2657–2663. https://doi.org/10.1038/sj.onc.1203603

Article  CAS  PubMed  Google Scholar 

Belapurkar P, Goyal P, Tiwari-Barua P (2014) Immunomodulatory effects of triphala and its individual constituents: a review. Indian J Pharm Sci 76:467–475. https://doi.org/10.4103/0250-474X.147214

Article  PubMed  PubMed Central  Google Scholar 

Boege Y, Malehmir M, Healy ME, Bettermann K, Lorentzen A, Vucur M, Ahuja AK, Böhm F, Mertens JC, Shimizu Y, Frick L, Remouchamps C, Mutreja K, Kähne T, Sundaravinayagam D, Wolf MJ, Rehrauer H, Koppe C, Speicher T, Padrissa-Altés S, Maire R, Schattenberg JM, Jeong JS, Liu L, Zwirner S, Boger R, Hüser N, Davis RJ, Müllhaupt B, Moch H, Schulze-Bergkamen H, Clavien PA, Werner S, Borsig L, Luther SA, Jost PJ, Weinlich R, Unger K, Behrens A, Hillert L, Dillon C, Di Virgilio M, Wallach D, Dejardin E, Zender L, Naumann M, Walczak H, Green DR, Lopes M, Lavrik I, Luedde T, Heikenwalder M, Weber A (2017) A dual role of caspase-8 in triggering and sensing proliferation-associated DNA damage, a key determinant of liver cancer development. Cancer Cell 32:342–359. https://doi.org/10.1016/j.ccell.2017.08.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G (2017) RESORCE Investigators. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 389:56–66. https://doi.org/10.1016/S0140-6736(16)32453-9

Article  CAS  PubMed  Google Scholar 

Budhu A, Wang XW (2006) The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 80:1197–1213. https://doi.org/10.1189/jlb.0506297

Article  CAS  PubMed  Google Scholar 

Cabillic F, Corlu A (2016) Regulation of transdifferentiation and retrodifferentiation by inflammatory cytokines in hepatocellular carcinoma. Gastroenterology 151:607–615. https://doi.org/10.1053/j.gastro.2016.06.052

Article  CAS  PubMed  Google Scholar 

Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL (2010) Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. Clin Cancer Res 16:5189–5199. https://doi.org/10.1158/1078-0432.CCR-09-3389

Article  CAS  PubMed  Google Scholar 

Chon YE, Jeong SW, Jun DW (2021) Hepatocellular carcinoma statistics in South Korea. Clin Mol Hepatol 27:512–514. https://doi.org/10.3350/cmh.2021.0171

Article  PubMed  PubMed Central  Google Scholar 

Chon YE, Park SY, Hong HP, Son D, Lee J, Yoon E, Kim SS, Ahn SB, Jeong SW, Jun DW (2023) Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly. Clin Mol Hepatol 29:120–134. https://doi.org/10.3350/cmh.2021.0395

Article  PubMed  Google Scholar 

Cichoz-Lach H, Michalak A (2014) Oxidative stress as a crucial factor in liver diseases. World J Gastroenterol 20:8082–8091. https://doi.org/10.3748/wjg.v20.i25.8082

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81–94. https://doi.org/10.1038/nrclinonc.2017.166

Article  CAS  PubMed  Google Scholar 

Dong C, Zhao B, Long F, Liu Y, Liu Z, Li S, Xuejun Y, Deguang S, Haibo W, Qinlong L, Rui L, Yan L, Zhenming G, Shujuan S, Qing R, Liming W (2016) Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein. Oncotarget 7: 8850–8865. https://doi.org/10.18632/oncotarget.7091

Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67:123–133. https://doi.org/10.1002/hep.29466

Article  CAS  PubMed  Google Scholar 

Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H (2009) TRAIL and other TRAIL Receptor agonists as novel cancer therapeutics. Adv Exp Med Biol 647:195–206. https://doi.org/10.1007/978-0-387-89520-8_14

Article  CAS  PubMed  Google Scholar 

Ferruzzi MG, Lobo JK, Janle EM, Cooper B, Simon JE, Wu QL, Welch C, Ho L, Weaver C, Pasinetti GM (2009) Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease. J Alzheimers Dis 18:113–124. https://doi.org/10.3233/JAD-2009-1135

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flohé L, Günzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121. https://doi.org/10.1016/s0076-6879(84)05015-1

Article  PubMed  Google Scholar 

Fu Y, Chung FL (2018) Oxidative stress and hepatocarcinogenesis. Hepatoma Res 4:39. https://doi.org/10.20517/2394-5079.2018.29

Fu Y, Liu S, Zeng S, Shen H (2019) From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res 38:396. https://doi.org/10.1186/s13046-019-1396-4

Article  PubMed  PubMed Central  Google Scholar 

Hung JH, Teng YN, Wang LH, Su IJ, Wang CC, Huang W, Lee KH, Lu KY, Wang LH (2011) Induction of Bcl-2 expression by hepatitis B virus pre-S2 mutant large surface protein resistance to 5-fluorouracil treatment in Huh-7 cells. PLoS ONE 6:e28977. https://doi.org/10.1371/journal.pone.0028977

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kartal-Yandim M, Adan-Gokbulut A, Baran Y (2016) Molecular mechanisms of drug resistance and its reversal in cancer. Crit Rev in Biotechnol 36:716–726. https://doi.org/10.3109/07388551.2015.1015957

Article  CAS